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Abstract 
The polychlorinated biphenyl group of possess high environmental persistence, leading to 
bioaccumulation and a number of adverse effects in mammals. Whilst coplanar PCBs elicit 
their toxic effects through agonism of the aryl hydrocarbon receptor; however, non-coplanar 
PCBs are not ligands for AhR, but may be ligands for members of the nuclear receptor family 
of proteins. To better understand the biological actions of non-coplanar PCBs, we have 
undertaken a systematic analysis of their ability to activate PXR and CAR-mediated effects 
Cells were exposed to a range of non-coplanar PCBs (99, 138, 153, 180 and 194), or the 
coplanar PCB77: Direct activation of PXR and CAR was measured using a mammalian 
receptor activation assay in human liver cells, with rifampicin and CITCO used as positive 
controls ligands for PXR and CAR, respectively; activation of target gene expression was 
examined using reporter gene plasmids for CYP3A4 and MDR1 transfected into liver, 
intestine and lung cell lines.   
Several of the non-coplanar PCBs directly activated PXR and CAR, whilst the coplanar 
PCB77 did not. Non-coplanar PCBs were also able to activate PXR/CAR target gene 
expression in a substitution- and tissue-specific manner.  
Non-coplanar PCBs act as direct activators for the nuclear receptors PXR and CAR, and are 
able to elicit transcriptional activation of target genes in a substitution- and tissue-dependent 
manner. Chronic activation of PXR/CAR is linked to adverse effects and must be included in 
any risk assessment of PCBs. 
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Introduction 
Polychlorinated biphenyls (PCBs) were historically used in a large number of industrial 
applications, including coolants, plasticisers, lubricants and insulators (Safe, 1984; Safe, 
2001). Their high chemical stability has resulted in environmental persistence, and coupled 
with their highly lipophilic nature raises the potential for bioaccumulation in higher 
mammals, including humans.  
There are 209 potential PCB congeners, of which 36 congeners are considered to be 
environmentally threatening due to environmental prevalence, bioaccumulation in animal 
tissues and known toxic effects (McFarland and Clarke, 1989). These congeners can be 
divided into non-ortho PCBs that have a coplanar configuration, and ortho-substituted PCBs 
with a non-coplanar configuration. PCB congeners with zero or one ortho-chlorine 
substituent (e.g. PCB77) exhibit toxic effects similar to 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD), and these are mediated through the aryl hydrocarbon receptor (AhR); thus, these 
PCBs are referred to as dioxin-like PCBs. These adverse effects include hepatotoxicity, 
elevated blood lipids, immune suppression, reproductive and developmental toxicity and 
carcinogenicity (Safe, 1984; Safe, 2001). Due to these highly undesirable properties, PCB 
manufacture was banned in the late 1970s and their usage severely restricted. However, due 
to the highly persistent nature of these chemicals, it is estimated that there remains over 
750,000 tonnes of PCBs in the biosphere, and hence they still represent an important potential 
toxic contaminant.  
Whilst the majority of risk assessment interest has focussed on the coplanar dioxin-like 
PCBs, non-coplanar PCBs are also highly environmentally prevalent, with PCB138, 153 and 
180 being widely present in the environment and thus must also be included in any 
hazard/risk assessment (Safe, 1994). Non-coplanar PCBs (e.g. PCB153) possess ortho 
chlorine substituents on the biphenyl ring that twists the structure away from a single plane. 
This significantly reduces the affinity for AhR, and indeed these compounds are likely to act 
as inhibitors of AhR-mediated activation (Suh et al., 2003). Non-coplanar PCBs are more 
likely to act as ligands for members of the nuclear receptor family of transcription factors 
(Wu et al., 2009). This activity may be important considering that not all of the adverse 
effects associated with PCB exposure are mediated via AhR. For example, the hydroxylated 
metabolites of PCBs are weak oestrogen receptor agonists, as well as inhibitors of oestrogen 
sulphotransferase; as such, PCBs may have an endocrine disrupting effect, which may 
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underlie their reproductive toxicity (Kester et al., 2000).  Thus it is important to assess the 
hazard of non-coplanar PCBs to humans to inform a full risk assessment 
It has been suggested that non-coplanar PCBs may act as ligands for the constitutive 
andorstane receptor (CAR) and/or the pregnane X receptor (PXR) (Schuetz et al., 1998; 
Jacobs et al., 2005), and may thus activate CAR/PXR target genes expression. Due to this 
activity, this group of PCBs is often referred to as ‘Phenobarbital-like PCBs’.  
There is thus a need to examine the non-AhR mediated effects of PCBs, and specifically the 
non-coplanar phenobarbital-like PBCs, for comprehensive risk assessments to be undertaken. 
As such, we have examined the ability of the non-coplanar PCBs PCB99, 138, 153, 180 and 
194 to directly activate CAR and PXR, as well as their ability to activate target gene 
expression in liver, lung and intestinal cells in vitro.   
 
Materials and Methods 
Reagents: Fugene-6 transfection reagent was purchased from Roche Diagnostics, Lewes, 
UK. Unless otherwise stated all other chemicals were of molecular biology grade and 
obtained from Sigma-Aldrich. (Poole, UK). The Huh7 human hepatocellular carcinoma cell 
line (Nakabayashi et al., 1982) was a kind gift from Dr Steve Hood (GSK, Ware, UK). 
Human intestinal (Caco2) and lung (A549) cell lines were purchased from ECACC (Porton 
Down, UK). All cells were routinely cultured in minimal essential medium with Earle’s salts 
supplemented with 1 % non-essential amino acids, 2 mM L-glutamine, 100U/ml penicillin, 
100 µg/ml streptomycin and 10 % foetal bovine serum. All cell culture medium and 
supplements were purchased from Invitrogen (Paisley, UK). In order to maintain phenotypic 
consistency, Huh7 cells were only used for three weeks (approximately 6 passages) following 
recovery from liquid nitrogen. The expression plasmid for PXR was kindly provided by Prof. 
S. Kliewer (University of Texas, Dallas, USA).  
Nuclear Receptor Activation Assay. Nuclear reporter activation assays were undertaken 
using a modification of the Checkmate mammalian two-hybrid system (Promega, UK), as 
described previously (Howe et al., 2011). Briefly, Huh7 cells were seeded into 96-well plates 
(Nunc International, Leicestershire, UK) at a concentration of 20,000 cells/well and incubated 
at 37 C for 24 hrs.  FuGENE 6-mediated DNA co-transfections, using 25ng/well luciferase 
reporter plasmid and 12.5ng/well NR-Gal4 fusion plasmid were undertaken, using serum-free 
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medium for the six-hour transfection period; this was then replaced with fresh, complete 
medium, containing charcoal-stripped serum, for the remaining culture period. The NR-Gal4 
construct encodes a fusion protein of the GAL4-DBD and an extended ligand binding region 
for human PXR or CAR, representing amino acids 141-434 and  162-348 respectively. 
Transfections were allowed to proceed for 24 hours, in the presence of PCB, positive control 
chemical or vehicle control (0.1% DMSO) as indicated, and then luciferase activity 
determined using the Dual-Luciferase reporter system (Promega, UK) according to the 
manufacturer’s protocol. Luminescent output was measured using a LumiCount automated 
plate reader (Canberra Packard, UK). 
Transcript level measurement: Specific primers and TAMRA/FAM dual labelled probe 
sets were designed against CYP1A1 and 18s using the Primer Express software (Applied 
Biosystems, Warrington, UK) and were purchased from Eurofins MWG (Wolverhampton, 
UK). 
Huh7, A549 or Caco2 cells were seeded into 96-well plates (Nunc International, 
Leicestershire, UK) at a concentration of 10,000 cells/well and incubated at 37 C for 24 hrs 
in a humidified container for attachment. Cells were exposed to PCB, positive control 
chemical or vehicle control as indicated for 48 hours. Following compound exposure, total 
RNA was extracted using the RNAeasy system (Qiagen, Crawley, UK) and treated with 
RNase-free DNase (Promega, Southampton, UK) to remove genomic contamination. Reverse 
transcription was primed with random hexamers and carried out by Superscript II 
(Invitrogen) as per the manufacturer’s instructions.  
cDNA was amplified using TaqMan Universal PCR Master Mix with 400 nM primers and 
200 nM fluorogenic probe in a total reaction volume of 25μl: cDNA generated from 50ng 
input total RNA was used per reaction to measure CYP1A1, whilst cDNA derived from 50pg 
input total RNA was used for 18s RNA quantitation. Quantitative polymerase chain reaction 
(Q-PCR) reactions were run on the ABI7000 SDS instrument and quantitation was carried 
out using the ABI proprietary software against a standard curve generated from human 
genomic DNA (Promega), and normalised against 18s rRNA expression levels. 
Reporter gene assay: Reporter gene assays were undertaken as described in Aouabdi et al 
(Aouabdi et al., 2006). Briefly, cells were seeded into 96-well plates (Nunc International, 
Leicestershire, UK) at a concentration of 10,000 cells/well and incubated at 37 C for 24 hrs 
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in a humidified container for attachment.  FuGENE 6-mediated DNA co-transfections, with 
75ng/well reporter gene constructs and 25ng/well over-expression plasmid as appropriate, 
were undertaken in serum-free medium for the six-hour transfection period; this was then 
replaced with fresh, complete medium, containing charcoal-stripped serum, for the remaining 
culture period.   
Transfections were allowed to proceed for 48 hours, in the presence of PCB, positive control 
chemical or vehicle control as indicated, and then secretory alkaline phosphatase (SEAP) 
activity determined. Endogenous alkaline phosphatase activity was deactivated by heat-
treatment of the medium at 65 °C for 30 minutes, and SEAP activity was assayed using the 
AURORA system (ICN, Thame, UK), according to the manufacturer’s protocol. 
Chemiluminescent output was measured using a LumiCount automated plate reader 
(Canberra Packard, UK), and fold induction relative to vehicle control calculated as described 
previously (Plant et al., 2000).  
Data was fitted to a non-linear regression model using GraphPad Prism v5.04 (La Jolla, CA, 
USA). The model utilised a four parameter variable slope to fit log(agonist) versus response, 
as given by the equation: Y=Bottom + (Top‐Bottom)/(1+10^((LogEC50‐X)*HillSlope)). 
Results 
A range of PCB congeners were selected for study that encompassed the coplanar PCB77, 
and the non-coplanar PCB99, 138, 153, 180 and 194 (Figure 1). Initially, we confirmed that 
only the coplanar PCB77 was able to activate AhR-mediated gene expression. Human liver, 
intestine and lung cell lines were exposed to each of the PCBs (10µM) for 48 hours and 
CYP1A1 transcript levels measured by Q-PCR. PCB77 elicited a significant increase in 
CYP1A1 transcript levels in all three cell lines; Caco2 cells were the most responsive, with 
Huh7 and A549 being equally responsive, demonstrating 64±6, 3.8±0.4 and 4.2±0.6 fold 
inductions versus vehicle control (0.1% DMSO), respectively (Figure 2). In contrast, none of 
the non-coplanar PCBs were able to significantly increase the level of CYP1A1. 
To examine the relationship between each PCB and the nuclear receptors PXR and CAR, we 
utilised a mammalian receptor activation assay, which contained extended ligand-binding 
domains for PXR and CAR respectively, to directly examine interactions. When transfected 
into Huh7 liver cells, the PXR activation reporter construct was activated by the positive 
control ligand rifampicin in a dose-dependent manner (maximum 7.6-fold versus vehicle 
control; Figure 3A), but was not activated by the coplanar PCB77. Within the non-coplanar 
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PCBs examined, the PXR activation assay was activated in a dose dependent manner by 
PCB138, 153, 180 and 194. PCB153 elicited the greatest effect, being approximately 
equipotent compared to rifampicin (maximum 9-fold versus vehicle control). The CAR 
activation assay was activated by the human-specific positive control agonist CITCO in a 
dose dependent manner (maximum 5.8-fold versus vehicle control; Figure 3B It was also 
activated by PCB99, 153, 180 and 194, although all were less potent than CITCO, producing 
maximal activations of 2.5-, 3.3-, 3.8- and 2.7-fold versus vehicle control, respectively. 
Having characterised the ability of selected non-coplanar PCBs to directly activate the 
nuclear receptors PXR and CAR, we next examined their ability to activate target gene 
expression for these nuclear receptors. We used reporter gene constructs for CYP3A4 and 
MDR1, which are classical target genes for PXR (Geick et al., 2001; Bombail et al., 2004; 
Plant, 2007), and can also be activated by CAR (Xie et al., 2000). Cells were exposed to the 
classical PXR agonist rifampicin (10µM), the mixed CAR/PXR agonist phenobarbital 
(500µM), or each PCB (10µM). 
In the human liver cell line Huh7, both rifampicin and phenobarbital activated expression of 
the CYP3A4 reporter gene (approximately 10- and 6-fold compared to vehicle control, 
respectively); no effect was observed on MDR1 reporter gene expression for either the 
upstream or downstream regulatory regions. Within the tested PCBs, only PCB153 had any 
significant impact on PXR/CAR-mediated gene expression, significantly increasing CYP3A 
reporter gene expression by approximately 7.6-fold compared to vehicle control (Figure 4A).  
In the colon-derived cell line Caco2, both rifampicin and phenobarbital increased CYP3A4 
reporter gene expression (9 and 4-fold compared to control, respectively). In addition, they 
also significantly activated the MDR1 upstream regulatory region, by 2.5- and 3.5-fold versus 
vehicle control, respectively. PCB153 was again able to increase CYP3A4 reporter gene 
activity (5.6-fold compared to vehicle control), and also increased MDR1 upstream 
regulatory region activity (3.8-fold compared to vehicle control), but had no effect on the 
MDR1 downstream regulatory region. PCB194 elicited a significant 2.6-fold increase in 
CYP3A4 reporter gene expression, but had no impact on either MDR1 reporter genes. All 
other PCBs tested had no effect on any of the reporter genes examined (Figure 4B) 
In general, effects within the lung cell line A549 were of a smaller magnitude compared to 
those observed in either the Huh7 or Caco2 cells (Figure 4C). Rifampicin did not increase 
CYP3A4 reporter gene expression, but did increase MDR1 upstream reporter gene expression 
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by 3-fold compared to vehicle control. In comparison, phenobarbital had no effect on MDR1 
reporter gene expression, but did significantly increase CYP3A4 reporter gene expression by 
4.3-fold compared to control. PCB138 increased CYP3A4 reporter gene expression, as did 
PCB153 (3.2- and 4-fold compared to vehicle control). PCB153 and PCB180 both increased 
expression of MDR1 reporter genes, although PCB153 increased the upstream regulatory 
region reporter (3.5-fold compared to vehicle control), whilst PCB180 increased the 
downstream regulatory region reporter (3-fold compared to vehicle control). 
PCB153 was selected for further analysis due to its direct and potent activation of both PXR 
and CAR, as well as its ability to activate PXR/CAR target gene expression, and its high 
environmental prevalence. Using the CYP3A4 and MDR1 reporter gene constructs we 
produced full concentration response curves in each of the three cell lines. As can be seen in 
figure 5A, in the Huh7 liver cell line, PCB153 is equipotent with rifampicin at activating the 
CYP3A4 reporter gene (EC50=5.5±1.3 and 6.8±1.4, respectively), consistent with its 
equipotent activation of PXR in the ligand binding assay (Figure 3). Both PCB153 and 
rifampicin have no significant effect on MDR1 reporter gene constructs in Huh7 cells, 
consistent with previous data (Figure 4).  
In contrast to the equipotent effect observed in the liver cell line, PCB153 was a more potent 
activator than rifampicin of the CYP3A4 reporter gene in Caco2 cells (EC50=1.5µM±2.3 and 
10µM±4.6, respectively; Figure 5B): However, the maximum induction observed was greater 
for rifampicin than PCB 153 (13.3±1.2 versus 6.1±0.4 cold compared to vehicle control, 
respectively). In addition, both rifampicin and PCB153 caused a dose-dependent increase in 
the MDR1 upstream regulatory region reporter gene: PCB153 was more potent that 
rifampicin (EC50= 1.3µM ±4.3 and 8.6µM±1.2, respectively), with the maximal induction 
observed for rifampicin (5.2-fold±0.3 compared to vehicle control) being greater than that 
observed with PCB153 (2.7-fold±0.3 compared to vehicle control). 
Both rifampicin and PCB153 were poor activators of CYP3A4 in the A549 lung cell line 
(figure 5C). Both compounds also failed to elicit statistically significant, dose-dependent, 
activation of the MDR1 upstream regulatory region, although rifampicin did cause an 
approximate 8-fold increase in MDR1 downstream regulatory region-mediated reporter gene 
activity at high concentrations. 
Discussion 
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Previous data has provided indirect evidence for the interaction of non-coplanar PCBs with 
the nuclear receptors PCR and CAR. Using a reporter gene system, Tabb et al were able to 
demonstrate that highly chlorinated, non-coplanar, PCBs were able to impact on 
PXR-mediated transcription (Tabb et al., 2004). Interestingly, they demonstrated that these 
highly chlorinated PCBs were able to activate reporter gene expression of target genes via 
mouse and rat PXR, but inhibited human PXR-mediated transcriptional events. Both PCB153 
and PCB 180 were demonstrated to exhibit Ki values in the low micromolar range, with 
PCB153 being the more potent inhibitor. In addition, PCB153 was demonstrated to bind to 
human PXR via a scintillation proximity assay; it is important to note that this assay is merely 
a binding assay and does not distinguish between agonist and antagonist behaviour. Herein, 
we demonstrate the ability of non-coplanar PCBs to both activate the nuclear receptors PXR 
and CAR in vitro, and also link this to tissue-specific activation of target gene expression. 
PCB153 has been shown to also be an agonist for the PXR paralogue CAR (Sakai et al., 
2006), although again this was only evident at relatively high concentrations, with significant 
activations occurring above 20ppm. Whilst our current data may initially appear 
contradictory to the suggestion that non-coplanar PCBs act as inhibitors of human PXR-
mediated transcriptional events. However, these data can be reconciled when one considers 
that inhibition of CYP3A reporter gene expression was observed by Tabb et al. at low 
micromolar concentrations, whilst we demonstrate activation of reporter gene expression at 
concentrations of 10µM; in addition, we demonstrate no direct activation of PXR or CAR by 
non-coplanar PCBs at 0.1µM, which is not inconsistent with the observations of Tabb et al.  
Taken together, such data may suggest that the mode-of-action for non-coplanar PCBs may 
be as mixed antagonist-agonists, with agonist activity only occurring at higher 
concentrations. Such a hypothesis is further supported by the work of Kopec et al, who 
studied the effect of non-coplanar PCBs on the murine transcriptome. In experiments where 
mice were exposed to 1-300mg/kg PCB153 for 24-168 hours, they observed an activation of 
“PXR/CAR target genes” that was not evident in mice exposed to the coplanar TCDD (Kopec 
et al., 2010). It should be noted that no attempt was made to delineate between PXR-specific 
and CAR-specific target genes, with this target gene set being treated as a single unit. 
Subsequently, Kopic et al also demonstrated that TCDD and PCB153 activate unique target 
gene sets even when given as a mixture, further supporting their alternate modes of action via 
the AhR and PXR/CAR, respectively (Kopec et al., 2011). The doses used in these studies 
achieved hepatic PCB153 concentration in the micromolar range, consistent with the in vitro 
doses used in our current work. 
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Given the suggested mixed agonist/antagonist of non-coplanar PCBs against human 
PXR/CAR, it is pertinent to consider what the likely human exposures are. Measurement of 
PCB levels in humans has been undertaken in a number of countries, with blood 
concentrations for PCB153 in the range 5-550 ng/g lipid having been reported (Petersen et 
al., 2007; Rudge et al., 2012). In addition, similar levels have been reported in fatty tissues 
such as breast (170±364 ng/g lipid (Petreas et al., 2011)), demonstrating the rapid distribution 
of these lipophilic compounds. Given the rapid and complete uptake of PCBs into human 
liver cells (Ghosh et al., 2010), it is likely that similar concentrations are found in the liver. 
As the lipid content of the liver is approximately 5% w/w (Garbow et al., 2004), it can be 
estimated that human liver concentrations are in the range 0.25-25ng/g total liver: This would 
equate to PCB concentrations in the low micromolar region, which is where effects were 
observed in the current study. Studies looking at the PCB burden in other tissues shows that 
there is, generally, only a small degree of variance between median tissue levels (expressed 
as ng/g lipid) throughout the body; hence, other tissue burdens can be expected to be within 
5-fold of the liver, meaning that these too likely to be within the micromolar range (Brandt 
and Bergman, 1987; Zhao et al., 2009). These estimates of PCB body burden, plus the 
activation data presented herein are therefore consistent with non-coplanar PCBs being able 
to activate PXR/CAR-dependent pathways at know human exposure levels. Indeed, Petersen 
et al. demonstrated that CYP3A activity was increased in Faroese adults with increased PCB 
exposure, which is supportive of PXR/CAR-mediated effects of PCBs occurring at 
physiologically relevant concentrations (Petersen et al., 2007).  
The differential effect of PCBs in human liver, lung and intestinal cell lines is of interest, and 
may be relevant to future risk assessments. The differential activation of target genes, is most 
probably reflective of the differential coregulator pool present in each tissue, and reflects the 
most efficient response to chemical challenge. For example, previous experiments 
demonstrated that CYP3A was induced in both rat liver and intestine following exposure to 
the PXR ligands dexamethasone and L742694 but that MDR1 was only increased in the 
intestine (Hartley et al., 2004); this most probably reflects the relative importance of 
metabolism and transport in chemical handling within the liver and intestine. The data 
presented herein is consistent with such a tissue-specific induction profile, and this may be 
important given that oral exposure is likely to be the most common route of non-occupational 
PCB exposure. Exposure to PCBs via inhalation is likely to be only a minimal non-
occupation exposure route, and herein we demonstrate that lung cells are relatively 
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insensitive to the PXR/CAR-mediated effects of non-coplanar PCBs. It should be noted that 
some caution must be applied when interpreting this data, as the in vitro experiments 
undertaken herein utilised transformed cell lines, which may not be fully representative of the 
in vivo tissue. However, we have selected those cell lines previously reported to be amongst 
the closest models of the relevant primary tissue (Lieber et al., 1976; Thelen and Dressman, 
2009; Lin et al., 2012), which may mitigate this potential confounder to some degree. 
Given the diverse functions that nuclear receptors undertake within the body in general 
(Bookout et al., 2006), and the liver specifically (Plant and Aouabdi, 2009), it is likely that 
agonism of PXR and/or CAR by non-coplanar PCBs may have impacts on these systems. In 
particular, nuclear receptors are associated with the regulation of metabolic homeostasis, 
through both the action of endosensing receptors such as LXR, FXR and PPAR (Barbier et 
al., 2002; Mohan and Heyman, 2003), and xenosensing receptors such as PXR and CAR 
(Bachmann et al., 2004; Pascussi et al., 2008; Wada et al., 2009). Thus, exposure to non-
coplanar PCBs may lead to chronic activation of PXR/CAR and potential dysfunction of 
these metabolic processes. Such effects have been reported for chronic exposure to other 
PXR/CAR ligands, supporting this hypothesis (Francis et al., 2003; Wada et al., 2009). 
Coupled with the reported association of coplanar PCB exposure and metabolic syndrome 
(Uemura et al., 2009), this highlights an important area for future risk assessment. 
In summary, we demonstrate that non-coplanar PCBs may act as direct activators of the 
nuclear receptors PXR and CAR, and that they are able to activate target gene expression in a 
tissue- and substituent-dependent manner. Considering that these effects occur at 
concentrations that have been measured in humans, and that chronic activation of PXR/CAR 
has been linked to metabolic dysfunction and disease, it is important that these effects are 
included in risk assessments. 
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Figure Legends 
 
Figure 1: Chemical structure of PCBs under study. 
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Figure 2: Induction of CYP1A1 transcripts PCBs in liver, intestine and lung cell lines. 
Huh7 (A), Caco2 (B) or A549 (C) cells were exposed to 10µM of the indicated chemical or 
vehicle control (0.1% DMSO) for 48 hours. Total RNA was extracted and then CYP1A1 
transcript level measured by TaqMan and normalised to the 18S transcript level. Each data 
point represents n=6, and statistical analysis was via one-way ANOVA; ***=p<0.001 relative 
to vehicle control. Graph is representative of triplicate repeat experiments. 
  
19 
 
 
 
Figure 3: Dose- and chemical-specific agonism of the nuclear receptors PXR and CAR 
by non-coplanar PCBs. Huh7 cells were transiently transfected with an expression plasmid 
for PXR (A) or CAR (B) LBD-Gal4 DBD fusion construct, plus a luciferase reporter plasmid. 
Cells were then exposed to 0.1µM, 1µM or 10µM of the indicated chemical or vehicle 
control (0.1% DMSO) for 24 hours, and then luciferase measured. Each data point represents 
n=6, and statistical analysis was via one-way ANOVA; *=p<0.01, **=p<0.05 and 
***=p<0.001 relative to vehicle control. Graph is representative of triplicate repeat 
experiments. 
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Figure 4: Chemical-specific activation of CYP3A4 and MDR1 reporter gene expression 
by PCBs. Huh7 (A), Caco2 (B) or A549 (C) cells were transiently transfected with a SEAP 
reporter gene under the control of the CYP3A4, MDR1 downstream (dsp) or upstream (usp) 
regulatory regions as indicated. Cells were then exposed to 10µM of the indicated chemical 
or vehicle control (0.1% DMSO) for 48 hours and SEAP activity measured, corrected for 
transfection efficiency, and presented as fold induction relative to vehicle control. Each data 
point represents n=6, and statistical analysis was via one-way ANOVA; *=p<0.01, 
**=p<0.05 and ***=p<0.001 relative to vehicle control. Graph is representative of at least 
triplicate repeat experiments. 
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Figure 5: Dose- and chemical-specific activation of CYP3A4 and MDR1 reporter gene 
expression by PCB153 and rifampicin occurs in a tissue-specificif manner. Huh7 (A), 
Caco2 (B) or A549 (C) cells were transiently transfected with a SEAP reporter gene under 
the control of the CYP3A4, MDR1 downstream (dsp) or upstream (usp) regulatory regions as 
indicated. Cells were then exposed to indicated concentrations of PCB153 or rifampicin, or 
vehicle control (0.1% DMSO) for 48 hours and SEAP activity measured, corrected for 
transfection efficiency, and presented as fold induction relative to vehicle control. Each data 
point represents n=6, and statistical analysis was via one-way ANOVA; *=p<0.01, 
**=p<0.05 and ***=p<0.001 relative to vehicle control. Graph is representative of at least 
triplicate repeat experiments. 
 
